ID   Ma-Mel-63b
AC   CVCL_C293
DR   cancercelllines; CVCL_C293
DR   Cosmic; 1846657
DR   Cosmic; 2686456
DR   ESTDAB; ESTDAB-220
DR   Wikidata; Q54903837
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-220
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   FGA: 22,23
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A198 ! Ma-Mel-63a
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
RX   PubMed=23348503; DOI=10.1126/science.1230062;
RA   Horn S., Figl A., Rachakonda P.S., Fischer C., Sucker A., Gast A.,
RA   Kadel S., Moll I., Nagore E., Hemminki K., Schadendorf D., Kumar R.;
RT   "TERT promoter mutations in familial and sporadic melanoma.";
RL   Science 339:959-961(2013).
//